Figure 3From: TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesOS comparison. Overall survival (OS) comparison with respect to TP53 mutation in patients with therapy-related myeloid neoplasm (t-MN) (A). OS comparison between t-MN with TP53 mutation and de novo MDS/AML with TP53 mutation (B). TP53 mut, patients with TP53 mutation; TP53 wt, patients with wild-type TP53.Back to article page